Close Menu

ELN

Benchmark led a new investment round in digital lab notebook maker Benchling, which claims 500 percent year-over-year growth in annual recurring revenue.

Core Informatics has satisfied Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice guidelines for the cloud version of its product.

Sapio Sciences said this week that the Epigenetics Center of the Institute for Basic Biomedical Sciences at Johns Hopkins University has licensed its Exemplar Laboratory Information Management System and Electronic Lab Notebook software.

Accelrys said Contur's offerings will complement the Symyx Notebook that the firm acquired through its merger with Symyx last year.

The deal builds on PerkinElmer's recent acquisitions of CambridgeSoft and ArtusLabs.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.